Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.215 USD | +9.20% | +10.27% | -26.82% |
05-15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
05-15 | Marker Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.82% | 34.43M | |
+50.30% | 56.87B | |
+37.15% | 39.72B | |
-5.91% | 39.27B | |
-6.90% | 28.73B | |
+13.17% | 26.21B | |
-15.66% | 19.79B | |
+31.23% | 12.28B | |
+28.20% | 12.23B | |
+0.66% | 12.12B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Transcript : Marker Therapeutics, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-16-2019 10